Racotumomab in Non-Small Cell Lung Cancer as Maintenance and Second-Line Treatment

INTRODUCTION Racotumomab is a therapeutic vaccine based on a monoclonal anti-idiotypic antibody developed by the Molecular Immunology Center in Havana, Cuba, that is registered in Cuba and Argentina for treatment of non-small cell lung cancer. It induces a specific humoral and cellular immune respo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MEDICC Review
Main Authors: Haslen H. Cáceres-Lavernia, Elia Nenínger-Vinageras, Leslie M. Varona-Rodríguez, Yoli A. Olivares-Romero, Irlis Sánchez-Rojas, Zaima Mazorra-Herrera, Denenke Basanta-Bergolla, Dayanis Duvergel-Calderín, Boris L. Torres-Cuevas, Concepción del Castillo-Carrillo
Formato: Artigo
Idioma:Inglês
Publicado em: Medical Education Cooperation with Cuba 2021
Assuntos:
Medicina
non
Cuba
carcinoma
Racotumomab
lung neoplasms
Acesso em linha:https://www.redalyc.org/articulo.oa?id=437571586005
https://www.redalyc.org/journal/4375/437571586005/
https://www.redalyc.org/journal/4375/437571586005/html/
https://www.redalyc.org/journal/4375/437571586005/437571586005.epub
https://www.redalyc.org/journal/4375/437571586005/movil
https://doi.org/10.37757/mr2021.v23.n3.5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados